Search Results - "Broom, R. J."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    The effects of sorafenib and sunitinib on bone turnover markers in patients with bone metastases from renal cell carcinoma by Sahi, C., Knox, J. J., Hinder, V., Deva, S., Cole, D., Clemons, M., Broom, R. J.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only e16145 Background: Bone metastases (BM) from renal cell carcinoma (RCC) are common and associated with poor outcomes. While the multi-tyrosine…”
    Get full text
    Journal Article
  2. 2

    Gene expression differences between disseminated tumor cells and tumor cells from overt bone metastases in patients with metastatic breast cancer by Broom, R. J., Amir, E., Cawthorn, T., Freedman, O., Gianfelice, D., Barth, D., Galica, J., Wang, D., Done, S. J., Clemons, M.

    Published in Journal of clinical oncology (20-05-2009)
    “…Abstract only 1040 Background: Despite extensive work evaluating molecular differences between primary tumors, circulating tumor cells, disseminated tumor…”
    Get full text
    Journal Article
  3. 3

    Changes in estrogen receptor (ER), progesterone receptor (PR) and HER2/neu status with time: Discordance rates between primary and metastatic breast pathology samples by Broom, R. J., Tang, P., Simmons, C., Bordeleau, L., O’Malley, F. P., Miller, N., Andrulis, I. L., Brenner, D. M., Clemons, M.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 1024 Background: The occurrence of changes in tumor receptor profile (ER, PR and HER-2/neu) between primary and metastatic tissue has been…”
    Get full text
    Journal Article